暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股市場個股詳情
PLUR Pluri Inc
- 5.6400
- +0.2700+5.03%
收盤價 05/02 16:00 (美東)
- 5.4900
- -0.1500-2.66%
盤後 16:17 (美東)
2924.35萬總市值-1215市盈率TTM
5.9000最高價5.4056最低價4.04萬股成交量5.6000今開5.3700昨收22.59萬成交額1.29%換手率虧損市盈率(靜)518.50萬總股本8.560052周最高6.65市淨率1767.16萬流通值3.448852周最低--股息TTM313.33萬流通股38400.0000歷史最高--股息率TTM9.21%振幅3.4488歷史最低5.5950平均價1股每手
盤後分時
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
資金分布
單位: --
資金流向
實時日周月
暫無數據
新聞
週四盤前交易時段，12只醫療保健股走勢
在週四的盤前交易中，GainersProcessa Pharma（納斯達克股票代碼：PCSA）股價上漲了31.2％，至2.12美元。該公司的市值爲600萬美元。Cyclacel 製藥（納斯達克股票代碼：CYCC）
快訊 | Pluri Inc：4月15日，收到納斯達克的來信，稱該公司已恢復遵守納斯達克上市規則5550 (a) (2)
週一盤後交易時段，12只醫療保健股走勢
在週一的盤後交易中，GainerSkineta（納斯達克股票代碼：KA）股價上漲了24.3％，至0.67美元。他們已發行股票的市值爲730萬美元。Moleculin Biotech（納斯達克股票代碼：MBRX）股票
行業最新消息：醫療保健股午後下跌
週一下午晚些時候，醫療保健股走軟，紐約證券交易所醫療保健指數和醫療保健精選板塊SPDR基金（XLV）各下跌約0.2％。iShares生物技術ETF（IBB）上漲了0。
行業更新：醫療保健
週一下午晚些時候，醫療保健股走軟，紐約證券交易所醫療保健指數和醫療保健精選板塊SPDR基金（XLV）各下跌0.2％。iShares生物技術ETF（IBB）上漲0.2％。在
Pluri 獲得美國免疫細胞擴張專利
Pluri（PLUR）週一表示，它已獲得一項新的美國免疫細胞擴張技術專利。新專利解決了異基因細胞療法中的挑戰，包括有限的捐贈者
評論
$Pluri Inc(PLUR.US$
NEWS
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
Pluri Inc. launched a novel immunotherapy platform for solid tumor cancer treatment utilizing placental MAIT cells, a unique type of immune cells with great potential. Pluri's proprietary technology overcomes challenges in expanding MAIT cells, offering advantages over conventional T cells. The global cancer immunotherapy market is projected to reach $275.11 ...
NEWS
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
Pluri Inc. launched a novel immunotherapy platform for solid tumor cancer treatment utilizing placental MAIT cells, a unique type of immune cells with great potential. Pluri's proprietary technology overcomes challenges in expanding MAIT cells, offering advantages over conventional T cells. The global cancer immunotherapy market is projected to reach $275.11 ...
Update
$Pluri Inc(PLUR.US$ Pluri Inc: on April 15, Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq Listing Rule 5550(a)(2)
News
$Pluri Inc(PLUR.US$ Pluri Introduces Groundbreaking Immune Cell Expansion Technology, Secures New US Patent
Benzinga· 1 min ago
Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a novel method for expansion of immune cells using proprietary technology and announced it was granted a new U.S. patent titled, "System and Methods for Immune Cells Ex...
Benzinga· 1 min ago
Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a novel method for expansion of immune cells using proprietary technology and announced it was granted a new U.S. patent titled, "System and Methods for Immune Cells Ex...
2
閱讀更多
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅